Geron discontinues late-stage trial of blood cancer drug

Geron discontinues late-stage trial of blood cancer drug

来源:Reuters发布于 2026-10-28

Geron said on ‌Wednesday it would discontinue a late-stage trial testing its treatment for ​patients with a form ​of rare blood cancer.

相关标的:GERN

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。